Simple Summary People with cancer are at an increased risk of developing blood clots. Both
cancer and anti-cancer treatment are responsible for this risk. In some types of cancer, such …

Cancer is a hypercoagulable state with an associated increased risk of venous
thromboembolism (vte) that is further amplified in individuals who undergo chemotherapy …

Venous thromboembolic disease can be a fatal complication of cancer. Despite advances in
prevention, thousands of patients require treatment of cancer-associated thrombosis (CAT) …

Cancer patients are at high risk for venous thromboembolism (VTE), which results in
substantial morbidity and mortality. In this narrative review, we present evidence for the use …

Venous thromboembolism (VTE) is a common disease in patients with cancer and carries a
poor prognosis. Although the exact incidence of VTE in patients with cancer lies between …

Cancer patients have a significant risk of developing venous thromboembolism (VTE); it
attributes as the second leading cause of death in this population.[1, 2] In addition, it …

Cancer-associated thrombosis (CAT) is a common occurrence in the journey of a cancer
patient and its management poses significant challenges. Low molecular weight heparin …

Venous thromboembolism (VTE) is a common cause of morbidity and mortality in cancer
patients and leads to a significant increase in health care costs. Cancer patients often suffer …

Although traditional anticoagulant regimens are highly effective and safe in most patients
with venous thromboembolism (VTE), the aggressive natural history of VTE and the high risk …

Patients with cancer‐associated thrombosis (CAT) carry a higher risk of recurrence,
bleeding and mortality as compared with non‐cancer patients. The specific profiles of cancer …